A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Clinical trial NCT05635344 · UNKNOWN

Trial details

NCT number: NCT05635344
Sponsor: Imperial College London
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gestational Trophoblastic Disease Gestational Trophoblastic Neoplasia Gestational Trophoblastic Tumor, Recurrent

Start date: 2024-02-14
Primary completion: 2026-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.